The Pistoia Alliance, a global, not for profit alliance that works to lower barriers to innovation in life sciences R&D, is calling upon the industry to improve collaborative efforts to use patient data to its full effect. In a series of keynote speeches delivered at The Pistoia Alliance’s annual member conference in London, speakers from Amgen, Accenture and AstraZeneca, discussed the need to more closely connect outcomes data with the R&D process – to help pharmaceutical companies focus their research efforts and deliver real benefits to patients. Building machine learning and deep learning systems, and incorporating data from therapeutic interventions or diagnostics into R&D is technologically challenging, and would benefit significantly from industry-wide pre-competitive collaboration...
In early July 2023, the World Health Organization (WHO) issued its 2023 report on Emerging Technologies and Scientific Innovations: A Global Public Health Perspective. This insightful and detailed report is the result of strategic engagement with a panel of global health experts through the use of an online Delphi method, roundtable discussions, and key informant interviews. The purpose of this report is to identify innovations in research and emerging technologies that have the potential to impact global health in the next five to ten years.